Exploring the benefits of prenatal aspirin in patients at risk for preeclampsia at Boston Medical Center
BACKGROUND: Preeclampsia is one of the leading causes of maternal and perinatal morbidity and mortality, affecting 2-8% of pregnancies worldwide. It is estimated that 76,000 women and 500,000 babies die from this disease each year globally. Preeclampsia is characterized as hypertension associated...
| Main Author: | |
|---|---|
| Other Authors: | |
| Language: | en_US |
| Published: |
2020
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2144/41784 |